Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -440,052 | -299,815 | -177,778 | -652,172 | -486,181 |
| Depreciation Amortization | 21,021 | 14,071 | 7,127 | 28,928 | 1,445 |
| Accounts receivable | -161,542 | -103,186 | -23,778 | 2,375 | 2,010 |
| Accounts payable and accrued liabilities | -19,450 | -9,849 | -5,854 | 18,689 | -4,437 |
| Other Working Capital | -157,707 | -100,151 | -35,811 | -15,763 | -11,277 |
| Other Operating Activity | 260,870 | 171,155 | 58,474 | 104,198 | 125,439 |
| Operating Cash Flow | $-496,860 | $-327,775 | $-177,620 | $-513,745 | $-373,001 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -678 | -631 | -259 | -1,524 | -673 |
| Purchase Of Investment | N/A | N/A | N/A | -331,863 | -331,863 |
| Sale Of Investment | N/A | N/A | N/A | 393,280 | 268,300 |
| Investing Cash Flow | $-678 | $-631 | $-259 | $59,893 | $-64,236 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 433,950 | 428,193 | 402,105 | 405,841 | 402,060 |
| Other Financing Activity | -35,538 | -35,527 | -10,999 | -40,182 | -20,455 |
| Financing Cash Flow | $398,412 | $392,666 | $391,106 | $365,659 | $381,605 |
| Exchange Rate Effect | -449 | 9 | 56 | -488 | -675 |
| Beginning Cash Position | 553,075 | 553,075 | 553,075 | 641,755 | 641,755 |
| End Cash Position | 453,500 | 617,344 | 766,358 | 553,074 | 585,448 |
| Net Cash Flow | $-99,575 | $64,269 | $213,283 | $-88,681 | $-56,307 |
| Free Cash Flow | |||||
| Operating Cash Flow | -496,860 | -327,775 | -177,620 | -513,745 | -373,001 |
| Capital Expenditure | -678 | -631 | -259 | -1,524 | -673 |
| Free Cash Flow | -497,538 | -328,406 | -177,879 | -515,269 | -373,674 |